DIALYSIS · CCN 332615

DaVita Central New York Dialysis Center

SYRACUSE, NY 13210

DialysisProfitDaVita
$8.6M
TOTAL REVENUE
18.0%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$8.6M
Total costs
$7.1M
Operating income (rev − costs)
$1.5M
Operating margin
18.0%
Total charges
$8.4M
Total treatments
21,939
Dialysis stations
30

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.46101—
Fistula Rate
DFC_FISTULA_RATE
58152—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.1382—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
153.8148—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
18152—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
24.5557—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
25.3141—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
25.3126—
Standardized ED Visits Ratio
DFC_SEDR
0.7776—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
32.162—